feed,title,long_url,short_url
Benzinga,Kymera's KT-474 Achieved Sustained IRAK4 Reduction After Single Dose In Healthy Volunteers,https://benzinga.com/general/biotech/21/06/21740259/kymeras-kt-474-achieved-sustained-irak4-reduction-after-single-dose-in-healthy-volunteers,https://j.mp/3hdvMHp
Benzinga,AstraZeneca Kick-Starts New COVID-19 Variant Vaccine Trial,https://benzinga.com/general/biotech/21/06/21742220/astrazeneca-kick-starts-new-covid-19-variant-vaccine-trial,https://j.mp/2ThOaH4
